RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections (Q66406472)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections |
clinical trial |
Statements
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis (English)
0 references
8 June 2016
0 references
23 November 2016
0 references
126
0 references
18 year
0 references